Patel Chirag K.
Insider CIK 1738701 · AMRX President, Co-CEO & Director, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, In | A Award | 2026-08-10 | 2026-08-12 | 6,381,734 | — | $0 | 6,381,734 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award | 2026-08-10 | 2026-08-12 | 6,381,734 | — | — | 6,381,734 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-04 | 2026-03-05 | 92,593 | — | $0 | 185,185 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-04 | 2026-03-05 | 37,825 | $13.30 | $503.1K | 1,393,470 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-04 | 2026-03-05 | 92,593 | — | $0 | 1,431,295 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 733,944 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 59,931 | — | $0 | 179,795 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 733,944 | — | $0 | 1,636,239 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 59,931 | — | $0 | 917,911 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 15,616 | $13.31 | $207.8K | 902,295 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 297,537 | $13.31 | $3.96M | 1,338,702 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 354,031 | — | $0 | 354,031 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 190,632 | — | $0 | 190,632 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-27 | 544,663 | — | $0 | 544,663 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-04 | 2025-03-05 | 92,592 | — | $0 | 277,778 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-04 | 2025-03-05 | 47,361 | $8.84 | $418.7K | 857,980 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-04 | 2025-03-05 | 92,592 | — | $0 | 905,341 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 579,710 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 890,410 | — | $0 | 890,410 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 239,726 | — | $0 | 239,726 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 279,527 | $8.76 | $2.45M | 812,749 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 579,710 | — | $0 | 1,092,276 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-06 | 370,370 | — | $0 | 370,370 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-06 | 1,333,334 | — | $0 | 1,333,334 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | J Other deriv | 2023-11-07 | 2023-11-08 | 21,269,420 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | J Other | 2023-11-07 | 2023-11-08 | 21,269,420 | — | $0 | 21,269,420 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 733,944 | — | $0 | 733,944 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 1,159,420 | — | $0 | 1,159,420 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2021-12-16 | 2021-12-17 | 50,000 | $4.25 | $212.5K | 512,566 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2021-12-15 | 2021-12-17 | 100,000 | $4.13 | $413.0K | 462,566 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 926,640 | — | $0 | 926,640 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-05-07 | 2020-05-08 | 6,459 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-05-07 | 2020-05-08 | 6,459 | — | $0 | 362,566 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2020-03-10 | 2020-03-11 | 100,000 | $3.09 | $309.0K | 356,107 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2020-03-04 | 2020-03-10 | 58,938 | $3.97 | $234.0K | 256,107 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2020-03-03 | 2020-03-10 | 156,421 | $3.88 | $606.9K | 197,169 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2020-03-02 | 2020-03-10 | 34,641 | $3.87 | $134.1K | 40,748 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 1,266,490 | — | $0 | 1,266,490 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2019-05-08 | 2019-05-08 | 6,107 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2019-05-08 | 2019-05-08 | 6,107 | — | $0 | 6,107 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-05-06 | 2019-05-08 | 28,044 | — | $0 | 28,044 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-05-06 | 2019-05-08 | 6,459 | — | $0 | 6,459 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | J Other deriv | 2018-07-05 | 2018-07-09 | 21,269,420 | — | $0 | 21,269,420 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | J Other | 2018-07-05 | 2018-07-09 | 21,269,420 | — | $0 | 21,269,420 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-09 | 24,977 | — | $0 | 24,977 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-09 | 6,107 | — | $0 | 6,107 | SEC↗ |